At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Want 3mg
Fragment 176-191 5MG $45.00 $200+ orders Discount per Quantity Scientific Overview of Fragment 176-191 Fragment 176-191, also referred to as hGH Fragment 176-191, tyr-hGH 177-191, or AOD-9604, is a synthetic segment derived from the terminal amino acid sequence of human growth hormone (hGH)
Great products, great customer service
Routine checkups typically dont test for it, and many symptoms associated with MTHFR mutations are misunderstood or misdiagnosed
American Journal of Case Reports
